Rizten-M Tablet
By Rizten-M
Rx
10 Tablet in a Strip

Composition
Levocetirizine(NA) + Montelukast(NA)

Manufacturer - National Chemical & Pharmaceuticals Works Pvt Ltd
20, Goyal Intercity Row House, Opp. T.V. Tower, Drive-in Road,

Expires on or after
October, 2025

liver
When taking Rizten-M Tablet, it is important to be cautious if you have severe liver disease. In such cases, it may be necessary to adjust the dosage of the medication. We advise you to consult your doctor before using Rizten-M Tablet if you have severe liver issues. It is also noted that there is limited information about the use of Rizten-M Tablet in patients with severe liver disease. However, for those with mild to moderate liver disease, no dose adjustment is typically required. If you have concerns about how Rizten-M Tablet may affect your liver health, please seek advice from your healthcare provider.

kidney
Rizten-M Tablet should be used carefully in patients with kidney disease. Dose adjustment may be necessary, and it is not recommended for those with severe kidney issues. Consult your doctor for guidance.

alcohol
When taking Rizten-M Tablet, it is recommended to use caution when drinking alcohol. Please seek advice from your doctor before consuming alcohol while on this medication.

driving
When taking Rizten-M Tablet, be cautious while driving as it may reduce alertness and cause drowsiness or dizziness. Avoid driving if experiencing these side effects.

pregnancy
Rizten-M Tablet is deemed safe for use during pregnancy. Animal studies indicate minimal risk to the baby, but human studies are limited.

breastfeeding
Caution Rizten-M Tablet is unsafe to use during breastfeeding as it may cause toxicity to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹104.73
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025